Financial Snapshot

Revenue
$13.02M
TTM
Gross Margin
-0.69%
TTM
Net Earnings
-$8.141M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
205.64%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
-$11.59M
Q4 2024
Cash
Q4 2024
P/E
-0.2572
Nov 29, 2024 EST
Free Cash Flow
-$17.03M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $20.16M $7.164M $16.36M $17.26M $8.464M $2.836M $2.170M
YoY Change 181.37% -56.22% -5.21% 103.96% 198.45% 30.69%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $20.16M $7.164M $16.36M $17.26M $8.464M $2.836M $2.170M
Cost Of Revenue $19.14M $10.30M $31.91M $32.93M $15.89M $9.240M $7.510M
Gross Profit $1.013M -$3.137M -$15.55M -$15.66M -$7.425M -$6.410M -$5.340M
Gross Profit Margin 5.03% -43.79% -95.01% -90.73% -87.72% -226.02% -246.08%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018
Selling, General & Admin $10.44M $14.07M $47.65M $63.52M $50.36M $26.85M $13.33M
YoY Change -25.81% -70.48% -24.98% 26.15% 87.57% 101.4%
% of Gross Profit 1030.21%
Research & Development $0.00 $3.482M $28.15M $36.68M $33.45M $15.00M $19.08M
YoY Change -100.0% -87.63% -23.25% 9.65% 123.03% -21.38%
% of Gross Profit 0.0%
Depreciation & Amortization $297.0K $191.0K $6.480M $5.800M $2.800M $2.280M $2.120M
YoY Change 55.5% -97.05% 11.72% 107.14% 22.81% 7.55%
% of Gross Profit 29.32%
Operating Expenses $1.070M $8.591M $76.86M $100.2M $83.81M $41.85M $32.41M
YoY Change -87.55% -88.82% -23.3% 19.56% 100.28% 29.12%
Operating Profit -$57.00K -$11.73M -$92.41M -$112.1M -$91.33M -$72.57M -$37.75M
YoY Change -99.51% -87.31% -17.58% 22.76% 25.86% 92.24%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018
Interest Expense $5.655M -$4.281M $5.677M $5.506M $22.27M -$4.930M
YoY Change -232.1% -175.41% 3.11% -75.27% -551.68%
% of Operating Profit
Other Income/Expense, Net -$4.479M -$130.0K $33.00K -$5.561M -$10.63M -$24.47M -$5.220M
YoY Change 3345.38% -493.94% -100.59% -47.66% -56.58% 368.77%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018
Pretax Income -$4.536M -$11.86M -$39.53M -$117.7M -$102.0M -$97.04M -$47.91M
YoY Change -61.75% -70.01% -66.41% 15.42% 5.07% 102.54%
Income Tax $0.00 $63.00K $82.00K $0.00 $23.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.547M -$81.66M -$39.62M -$117.7M -$102.0M -$97.04M -$47.91M
YoY Change -88.31% 106.14% -66.34% 15.39% 5.11% 102.54%
Net Earnings / Revenue -47.36% -1139.91% -242.11% -681.81% -1205.1% -3421.69% -2207.83%
Basic Earnings Per Share -$0.32 -$2.81 -$1.40 -$4.11 -$8.94
Diluted Earnings Per Share -$0.32 -$2.81 -$1.40 -$4.11 -$8.94 -$3.938M -$1.944M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $22.40M $70.45M $100.8M $131.1M $71.80M $17.70M
YoY Change -68.2% -30.09% -23.13% 82.59% 305.65%
Cash & Equivalents $19.17M $25.58M $24.07M $25.20M $9.500M $9.600M
Short-Term Investments $3.233M $44.86M $76.70M $105.8M $62.40M $8.100M
Other Short-Term Assets $8.218M $13.01M $5.476M $5.200M $2.000M $1.100M
YoY Change -36.82% 137.55% 5.31% 160.0% 81.82%
Inventory $4.278M $13.33M $16.41M $13.00M $8.400M $3.000M
Prepaid Expenses
Receivables $11.35M $21.09M $3.633M $2.200M $300.0K $200.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $46.25M $117.9M $126.3M $151.4M $82.50M $21.90M
YoY Change -60.76% -6.67% -16.59% 83.52% 276.71%
Property, Plant & Equipment $4.014M $13.09M $18.19M $14.00M $6.800M $3.900M
YoY Change -69.34% -28.02% 29.94% 105.88% 74.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $7.120M $8.700M
YoY Change -100.0% -18.16%
Other Assets $3.694M $897.0K $1.152M $700.0K $100.0K $100.0K
YoY Change 311.82% -22.14% 64.57% 600.0% 0.0%
Total Long-Term Assets $7.708M $15.57M $43.50M $41.10M $23.00M $4.000M
YoY Change -50.5% -64.2% 5.84% 78.7% 475.0%
Total Assets $53.96M $133.4M $169.8M $192.5M $105.5M $25.90M
YoY Change
Accounts Payable $2.761M $4.721M $7.519M $8.300M $3.900M $1.600M
YoY Change -41.52% -37.21% -9.41% 112.82% 143.75%
Accrued Expenses $3.605M $10.01M $9.090M $7.900M $10.60M $4.800M
YoY Change -63.97% 10.07% 15.06% -25.47% 120.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $11.30M
YoY Change -100.0%
Long-Term Debt Due $1.864M $1.800M $1.500M $5.400M $8.200M $0.00
YoY Change 3.56% 20.0% -72.22% -34.15%
Total Short-Term Liabilities $18.94M $19.87M $18.51M $21.90M $31.90M $24.90M
YoY Change -4.68% 7.36% -15.48% -31.35% 28.11%
Long-Term Debt $32.65M $34.43M $40.92M $42.90M $43.90M $14.60M
YoY Change -5.17% -15.84% -4.63% -2.28% 200.68%
Other Long-Term Liabilities $3.243M $4.115M $4.641M $1.100M $2.100M $0.00
YoY Change -21.19% -11.33% 321.91% -47.62%
Total Long-Term Liabilities $35.90M $38.55M $45.56M $44.00M $46.00M $14.60M
YoY Change -6.88% -15.38% 3.54% -4.35% 215.07%
Total Liabilities $54.84M $58.42M $64.07M $66.00M $77.90M $39.50M
YoY Change -6.13% -8.81% -2.93% -15.28% 97.22%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 29.77M shares 29.10M shares 28.32M shares 28.65M shares 11.41M shares
Diluted Shares Outstanding 29.77M shares 29.10M shares 28.32M shares 28.65M shares 11.41M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $2.0939 Million

About Acutus Medical, Inc.

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 233 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES ALR TECHNOLOGIES INC. RemSleep Holdings Inc. DELCATH SYSTEMS, INC. STRATA Skin Sciences, Inc. OMNIA WELLNESS INC. HeartBeam, Inc. MINERVA SURGICAL INC NeuroMetrix, Inc. NEUROONE MEDICAL TECHNOLOGIES Corp